Emma O. Billington
YOU?
Author Swipe
View article: Barriers and facilitators to following dietary recommendations for bone health: a qualitative study
Barriers and facilitators to following dietary recommendations for bone health: a qualitative study Open
Our findings indicate that adults with or at risk of osteoporosis face multiple barriers to adhering with dietary recommendations. Bone-focused Culinary Medicine programming merits further study as a possible method of overcoming these bar…
View article: Strength training for osteoporosis prevention during early menopause (STOP-EM): a pilot study protocol for a single centre randomised waitlisted control trial in Canada
Strength training for osteoporosis prevention during early menopause (STOP-EM): a pilot study protocol for a single centre randomised waitlisted control trial in Canada Open
Introduction Women lose up to 10% of their bone mass around menopause and the decade following. There is a need for proactive approaches to preserve bone mass and quality around menopause. Existing work has found that high-intensity resist…
View article: A243 BONE MINERAL DENSITY AND DIETARY BONE NUTRIENTS DIFFER IN PATIENTS WITH CROHN'S DISEASE STRICTURES
A243 BONE MINERAL DENSITY AND DIETARY BONE NUTRIENTS DIFFER IN PATIENTS WITH CROHN'S DISEASE STRICTURES Open
Background Crohn’s disease (CD) phenotypes include inflammatory (non-stricture) and stricture behaviours. Strictures are bowel narrowing’s that may lead to obstructions and subsequent dietary restrictions to prevent blockages. Bone mineral…
View article: Effectiveness and Cost of Using Facebook Recruitment to Elicit Canadian Women’s Perspectives on Bone Health and Osteoporosis: Cross-Sectional Survey Study
Effectiveness and Cost of Using Facebook Recruitment to Elicit Canadian Women’s Perspectives on Bone Health and Osteoporosis: Cross-Sectional Survey Study Open
Background Surveys can help health researchers better understand the public’s perspectives and needs regarding prevalent conditions such as osteoporosis, which affects more than two-thirds of postmenopausal women. However, recruitment of l…
View article: Bisphosphonates Preserve Bone Mineral Density and Suppress Bone Turnover Markers in Early Menopausal Women: A Systematic Review and Meta‐Analysis of Randomized Trials
Bisphosphonates Preserve Bone Mineral Density and Suppress Bone Turnover Markers in Early Menopausal Women: A Systematic Review and Meta‐Analysis of Randomized Trials Open
Most women do not qualify for pharmacologic osteoporosis treatment until more than a decade after menopause, by which time they will have lost up to 30% of their bone mass and may have already sustained fractures. Short or intermittent cou…
View article: A225 QUANTIFICATION OF BONE DENSITY AND DIETARY RISK FACTORS FOR BONE FRAGILITY IN INFLAMMATORY BOWEL DISEASE
A225 QUANTIFICATION OF BONE DENSITY AND DIETARY RISK FACTORS FOR BONE FRAGILITY IN INFLAMMATORY BOWEL DISEASE Open
Background Nutrition and bone fracture risk are intimately related in inflammatory bowel disease (IBD). Crohn’s disease (CD) patients are at increased risk of low bone mineral density (BMD) and fractures. This may be due to chronic inflamm…
View article: A retrospective review of the community medicine needs from osteoporosis services in Canada
A retrospective review of the community medicine needs from osteoporosis services in Canada Open
View article: Response to High‐Dose Vitamin D Supplementation Is Specific to Imaging Modality and Skeletal Site
Response to High‐Dose Vitamin D Supplementation Is Specific to Imaging Modality and Skeletal Site Open
High‐dose vitamin D supplementation (4000 or 10,000 IU/d) in vitamin D‐sufficient individuals results in a dose‐dependent decrease in radius and tibia total bone mineral density (Tt.BMD) compared with 400 IU/d. This exploratory analysis ex…
View article: Comparison of 2 fracture risk estimation processes in Alberta: a cross-sectional chart review
Comparison of 2 fracture risk estimation processes in Alberta: a cross-sectional chart review Open
Fracture risk estimates on BMD reports (using the CAROC tool) and those calculated in the clinical setting (using FRAX) frequently result in different risk classification. Osteoporosis treatment decisions may differ in up to half of patien…
View article: Reply to Burt LA, et al.: Adverse Effects of High-Dose Vitamin D Supplementation on Volumetric Bone Density Are Greater in Females Than Males
Reply to Burt LA, et al.: Adverse Effects of High-Dose Vitamin D Supplementation on Volumetric Bone Density Are Greater in Females Than Males Open
We thank Dr Boucher(1) for her comments on our findings and hope our response provides further clarification. It is important to emphasize that our results are based on exploratory outcomes from our randomized controlled trial, and it is o…
View article: Reply to Vitamin D Supplements: Is Bone Loss by HR-pQCT Really Negative?
Reply to Vitamin D Supplements: Is Bone Loss by HR-pQCT Really Negative? Open
The author questions whether the dose-response effect of vitamin D supplementation we showed using HR-pQCT should be of concern to clinicians, particularly because those findings were not reflected in our DXA-based area BMD (aBMD) measures…
View article: Hip Fractures in Older Adults Are Associated With the Low Density Bone Phenotype and Heterogeneous Deterioration of Bone Microarchitecture
Hip Fractures in Older Adults Are Associated With the Low Density Bone Phenotype and Heterogeneous Deterioration of Bone Microarchitecture Open
Femoral neck areal bone mineral density (FN aBMD) is a key determinant of fracture risk in older adults; however, the majority of individuals who have a hip fracture are not considered osteoporotic according to their FN aBMD. This study us…
View article: Effect of a Three-Day Course of Dexamethasone on Acute Phase Response Following Treatment With Zoledronate: A Randomized Controlled Trial
Effect of a Three-Day Course of Dexamethasone on Acute Phase Response Following Treatment With Zoledronate: A Randomized Controlled Trial Open
Zoledronate is a potent intravenous bisphosphonate effective in the management of osteoporosis, Paget's disease and skeletal-related events in malignancy. Its most frequent adverse effect is the acute phase response (APR), an inflammatory …
View article: Reply to Effects of High-Dose Vitamin D Supplementation on Bone Fragility
Reply to Effects of High-Dose Vitamin D Supplementation on Bone Fragility Open
We thank Dr Sugiyama for his response to our article. Dr Sugiyama raises the interesting possibility that high-dose vitamin D causes an increase in serum calcium (as found in our study), which, in turn, might mediate the decrease in volume…
View article: Group medical consultation for osteoporosis: a prospective pilot study of patient experience in Canadian tertiary care
Group medical consultation for osteoporosis: a prospective pilot study of patient experience in Canadian tertiary care Open
Background Delivery of patient-centred care is limited by physician time. Group medical consultations may save physician time without compromising patient experience. Aim To assess patient experience and specialist physician time commitmen…
View article: Fracture risk assessment in Canada: Bone mineral density reports and osteoporosis specialists do not agree
Fracture risk assessment in Canada: Bone mineral density reports and osteoporosis specialists do not agree Open
View article: Adverse Effects of High-Dose Vitamin D Supplementation on Volumetric Bone Density Are Greater in Females than Males
Adverse Effects of High-Dose Vitamin D Supplementation on Volumetric Bone Density Are Greater in Females than Males Open
Three years of high-dose vitamin D supplementation (400 IU, 4000 IU, 10,000 IU) in healthy vitamin D–sufficient individuals aged 55 to 70 years (serum 25(OH)D 30–125 nmol/L at baseline), resulted in a negative dose-response relationship fo…
View article: SUN-374 Decisions to Accept or Decline Pharmacologic Osteoporosis Therapy After Attending a Novel Patient-Centred Educonsult Program for Osteoporosis (PEP-OP)
SUN-374 Decisions to Accept or Decline Pharmacologic Osteoporosis Therapy After Attending a Novel Patient-Centred Educonsult Program for Osteoporosis (PEP-OP) Open
Osteoporosis affects >200 million people, resulting in >8.9 million annual fragility fractures worldwide. Available medications can reduce fracture risk by 40–60%, although access to specialty osteoporosis services is limited, and ma…
View article: Postural Balance Effects Associated with 400, 4000 or 10,000 IU Vitamin D3 Daily for Three Years: A Secondary Analysis of a Randomized Clinical Trial
Postural Balance Effects Associated with 400, 4000 or 10,000 IU Vitamin D3 Daily for Three Years: A Secondary Analysis of a Randomized Clinical Trial Open
Vitamin D supplementation is proposed as a fall prevention strategy, as it may improve neuromuscular function. We examined whether three years of vitamin D supplementation (400, 4000 or 10,000 IU daily) affects postural sway in older adult…
View article: At Odds About the Odds: Women’s Choices to Accept Osteoporosis Medications Do Not Closely Agree with Physician-Set Treatment Thresholds
At Odds About the Odds: Women’s Choices to Accept Osteoporosis Medications Do Not Closely Agree with Physician-Set Treatment Thresholds Open
View article: Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength
Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength Open
ClinicalTrials.gov Identifier: NCT01900860.
View article: Fibroblast growth factor 23 levels decline following sleeve gastrectomy
Fibroblast growth factor 23 levels decline following sleeve gastrectomy Open
Objective Levels of fibroblast growth factor 23 (FGF23) have been positively associated with measures of adiposity, cardiovascular disease and mortality. It is unclear whether the relationship of FGF23 with cardiovascular disease and morta…
View article: Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men
Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men Open
Hyperparathyroidism may be associated with skeletal and cardiovascular abnormalities, but it is unclear whether these associations exist for high-normal levels of parathyroid hormone (PTH). We assessed relationships between PTH and anthrop…
View article: The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis
The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis Open
View article: Endocrine Aspects of 4H Leukodystrophy: A Case Report and Review of the Literature
Endocrine Aspects of 4H Leukodystrophy: A Case Report and Review of the Literature Open
Introduction . 4H leukodystrophy is an autosomal recessive RNA polymerase III-related leukodystrophy, characterized by hypomyelination, with or without hypodontia (or other dental abnormalities) and hypogonadotropic hypogonadism. Case Pres…